effect of Intrathecal Pethidine on Incidence & Severity of Shivering during Cesarean section under Spinal anesthesia in Dilla University Referral Hospital, Randomized controlled trial

effect of Intrathecal Pethidine on Incidence & Severity of Shivering during Cesarean section under Spinal anesthesia from April 2020 to January 2021

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202110617970232

Enrollment

Registered

2021-10-20

Start date

2021-10-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Anaesthesia

Interventions

intrathecal pethidine

control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All elective ASA I & II pregnant mother

Exclusion criteria

Exclusion criteria: Initial body temperature 38 degree Celsius, Allergy history to pethidine & LA agent Patient who received thermoregulatory medication or antipsychotic medication, History of alcohol or substance abuse History of cardiovascular disease Preclampsia, Antepartum hemorrhage

Design outcomes

Primary

Measure	Time frame
incidence and severity of shivering	—

Secondary

Measure	Time frame
postoperative nausea and vomitingpruritus	—

Countries

Ethiopia

Contacts

Public ContactTimsel Girma

principal investigator

timsikebron15@gmail.com+251944060952

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026